Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian CancerTimothy R. Rebbeck, Saundra S. Buys, Nandita Mitra et al.|JAMA|2015Cited by 507
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i>Xin Yang, Mark E. Robson, Richard S. Houlston et al.|JNCI Journal of the National Cancer Institute|2020Cited by 163
Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragilityIrene Catucci, Paolo Peterlongo, Brita Arver et al.|Genetics in Medicine|2017Cited by 93
Implementing precision medicine in a regionally organized healthcare system in SwedenThoas Fioretos, Richard Rosenquist, Valtteri Wirta et al.|Nature Medicine|2022Cited by 42
Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in GermanyAlbrecht Stenzinger, Verena I. Gaidzik, Anders Edsjö et al.|Seminars in Cancer Biology|2021Cited by 38